Subscribe To

Price Alert Latest News Economic Calendar News

FBIO / Fortress Biotech to Participate in Two Upcoming May 2022 Investor Conferences

MIAMI, May 18, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in two investor conferences in May 2022. Read More

Demo Live Account See Partner Details

Content Topics

Fortress

Biotech

Participate

Upcoming

2022

Investor

Conferences

Stock

FBIO

Posted: May 18 2022, 08:30

Author Name: GlobeNewsWire

FBIO News

By GlobeNewsWire
September 7, 2023

Fortress Biotech to Present at H.C. Wainwright 25th Annual Global Investment Conference

MIAMI, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on e

By GlobeNewsWire
May 19, 2023

Journey Medical Corporation to Announce First Quarter 2023 Financial Results on May 22, 2023

Company to host conference call to discuss financial results and provide a corporate update on May 22, 2023 at 4:30 p.m. ET Company to host conference

By Zacks Investment Research
May 15, 2023

Fortress Biotech (FBIO) Reports Q1 Loss, Lags Revenue Estimates

Fortress Biotech (FBIO) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to los

By GlobeNewsWire
March 22, 2023

Journey Medical Corporation to Announce Year End 2022 Financial Results on March 29, 2023

Company to host conference call to discuss financial results and provide a corporate update on March 29, 2023 at 4:30 p.m. ET Company to host conferen

By GlobeNewsWire
May 18, 2022

Fortress Biotech to Participate in Two Upcoming May 2022 Investor Conferences

MIAMI, May 18, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on eff

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.